A Phase 1 Study of TDM-105795 Topical Solution in Male Subjects With Androgenetic Alopecia (AGA)

NCT04913519 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Alopecia, Androgenetic

Interventions

DRUG: TDM-105795
DRUG: Placebo

Sponsor

Technoderma Medicines Inc.

Collaborators

[object Object]